- Home
- IKT vs EBMT Comparison
IKT vs EBMT Comparison
Compare IKT & EBMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKT
- EBMT
- Stock Information
- Founded
- IKT 2008
- EBMT 1922
- Country
- IKT United States
- EBMT United States
- Employees
- IKT N/A
- EBMT N/A
- Industry
- IKT Biotechnology: Pharmaceutical Preparations
- EBMT Major Banks
- Sector
- IKT Health Care
- EBMT Finance
- Exchange
- IKT Nasdaq
- EBMT Nasdaq
- Market Cap
- IKT 167.2M
- EBMT 133.9M
- IPO Year
- IKT 2020
- EBMT N/A
- Fundamental
- Price
- IKT $1.90
- EBMT $16.53
- Analyst Decision
- IKT Buy
- EBMT
- Analyst Count
- IKT 2
- EBMT 0
- Target Price
- IKT $8.00
- EBMT N/A
- AVG Volume (30 Days)
- IKT 147.0K
- EBMT 43.2K
- Earning Date
- IKT 05-14-2025
- EBMT 04-29-2025
- Dividend Yield
- IKT N/A
- EBMT 3.46%
- EPS Growth
- IKT N/A
- EBMT N/A
- EPS
- IKT N/A
- EBMT 1.24
- Revenue
- IKT N/A
- EBMT $80,696,000.00
- Revenue This Year
- IKT N/A
- EBMT N/A
- Revenue Next Year
- IKT N/A
- EBMT $6.33
- P/E Ratio
- IKT N/A
- EBMT $13.33
- Revenue Growth
- IKT N/A
- EBMT N/A
- 52 Week Low
- IKT $1.12
- EBMT $12.32
- 52 Week High
- IKT $4.20
- EBMT $18.37
- Technical
- Relative Strength Index (RSI)
- IKT 42.84
- EBMT 51.21
- Support Level
- IKT $1.58
- EBMT $15.55
- Resistance Level
- IKT $2.22
- EBMT $16.27
- Average True Range (ATR)
- IKT 0.22
- EBMT 0.55
- MACD
- IKT 0.00
- EBMT 0.01
- Stochastic Oscillator
- IKT 45.57
- EBMT 75.15
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease ("PD"), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
About EBMT Eagle Bancorp Montana Inc.
Eagle Bancorp Montana Inc operates as a bank holding company. It provides loan and deposit services. The company focuses on residential loans, commercial real estate loans, commercial loans, consumer loans, and home equity loan products. The bank also offers deposit accounts which include checking, savings, money market, individual retirement accounts, and certificates of deposit accounts. It is a diversified lender with a focus on residential mortgage loans, commercial real estate mortgage loans, commercial business loans, agricultural loans, and second mortgage/home equity loan products.